Viking Therapeutics (NASDAQ: VKTX), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A decision is expected in the fourth quarter of 2025.

Novo Nordisk (NVO) stock in focus as oral Wegovy is accepted for FDA review for chronic weight management. Read more here.

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

Shares in Berkshire Hathaway hit a record high closing price of $537.72 on the day Trump unveiled sweeping tariffs, which the president dubbed "Liberation Day". The stock fell sharply in the following ...

Patients will be able to get weight loss injections from pharmacies, according to reports. It's claimed drugs such as Ozempic ...

But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...